Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization

被引:159
作者
Kimber, I
Cumberbatch, M
Dearman, RJ
Bhushnan, M
Griffiths, CEM
机构
[1] AstraZeneca, Cent Toxicol Lab, Macclesfield SK10 4TJ, Cheshire, England
[2] Univ Manchester, Hope Hosp, Dermatol Ctr, Salford M6 8HD, Lancs, England
关键词
chemokines; cytokines; dendritic cells; Langerhans cells; migration;
D O I
10.1046/j.1365-2133.2000.03349.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Langerhans cells (LC) are members of the wider family of dendritic cells, LC reside in the epidermis where they serve as sentinels of the immune system, their responsibilities being to sample the external environment for changes and challenges and to deliver information (antigen) to responsive T lymphocytes within skin draining lymph nodes. The ability of LC to migrate from the epidermis to regional lymph nodes is therefore of pivotal importance to the induction of cutaneous immune responses. The journey that LC have to make from the skin has a number of requirements, Initially it is necessary that LC disassociate themselves from surrounding keratinocytes and are liberated from other influences that encourage their retention in the epidermis, Subsequently migrating LC must successfully traverse the basement membrane of the dermal-epidermal junction and make their way, via afferent lymphatics, to draining lymph nodes. Effective entry into lymph nodes is necessary as is correct positioning of cells within the paracortex. There is increasing evidence that both cytokines and chemokines, and their interaction with appropriate receptors expressed by LC, orchestrate the mobilization and movement of these cells. We here consider the parts played by these molecules, and how collectively they induce and direct LC migration.
引用
收藏
页码:401 / 412
页数:12
相关论文
共 164 条
  • [71] THE ROLE OF DENDRITIC CELLS IN THE INITIATION OF IMMUNE-RESPONSES TO CONTACT SENSITIZERS .1. INVIVO EXPOSURE TO ANTIGEN
    KNIGHT, SC
    KREJCI, J
    MALKOVSKY, M
    COLIZZI, V
    GAUTAM, A
    ASHERSON, GL
    [J]. CELLULAR IMMUNOLOGY, 1985, 94 (02) : 427 - 434
  • [72] Knight SC, 1998, EUR J IMMUNOL, V28, P1636
  • [73] Langerhans' cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens
    Kobayashi, Y
    [J]. IMMUNOLOGY, 1997, 90 (04) : 496 - 501
  • [74] TUMOR NECROSIS FACTOR-ALPHA MAINTAINS THE VIABILITY OF MURINE EPIDERMAL LANGERHANS CELLS IN CULTURE, BUT IN CONTRAST TO GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR, WITHOUT INDUCING THEIR FUNCTIONAL MATURATION
    KOCH, F
    HEUFLER, C
    KAMPGEN, E
    SCHNEEWEISS, D
    BOCK, G
    SCHULER, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) : 159 - 171
  • [75] Koch F, 1997, J INVEST DERMATOL, V109, P29
  • [76] KRIPKE ML, 1990, J IMMUNOL, V145, P2833
  • [77] Are CD8(+) dendritic cells (DC) veto cells? The role of CD8 on DC in DC development and in the regulation of CD4 and CD8 T cell responses
    Kronin, V
    Vremec, D
    Winkel, K
    Classon, BJ
    Miller, RG
    Mak, TW
    Shortman, K
    Suss, G
    [J]. INTERNATIONAL IMMUNOLOGY, 1997, 9 (07) : 1061 - 1064
  • [78] Kronin V, 1996, J IMMUNOL, V157, P3819
  • [79] Developmental regulation of dendritic cell function
    Lane, PJL
    Brocker, T
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (03) : 308 - 313
  • [80] The role of dendritic cells in cutaneous immunity
    Lappin, MB
    Kimber, I
    Norval, M
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1996, 288 (03) : 109 - 121